Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Sarcoma
How do you delineate Postoperative Target Volumes in Extremity Sarcoma Cases Following Neoadjuvant Chemotherapy and Surgery?
Related Questions
How do you sequence treatment for a patient following R2 resection of a large extremity leiomyosarcoma who has small lung nodules concerning for metastatic disease, but not yet biopsy proven?
Would you recommend post operative radiation in an adult patient with a thoracic spine osteosarcoma?
Would you use neoadjuvant TKI or neoadjuvant radiation for a large chest wall sarcoma with an NTRK fusion on NGS?
What dose fractionation would you consider for adjuvant reirradiation for locally recurrent epithelioid sarcoma?
How do you approach patients with osteosarcoma of the maxilla for neoadjuvant chemotherapy?
How do you approach a patient with undifferentiated pleomorphic sarcoma encasing the spinal cord post radiation for neurological deficits for further management?
How would you approach patients with primary cardiac sarcomas for adjuvant systemic treatment?
Would you recommend radiation therapy for an adult patient with rhabdomyosarcoma (embryonal) of the upper extremity s/p amputation with multiple lymph node involvement and ENE on pathology?
Would you offer adjuvant radiation for a DFSP with fibrosarcomatous transformation s/p wide local excision?
When evaluating for PMRT in patients who did not receive neoadjuvant chemotherapy and are found to be pN0, do you utilize clinical T-staging, or pathologic T-staging?
